APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneOperatingExpenses01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:FourOperatingExpenses01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentRevenue02Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:FourReportableSegmentRevenue02Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentResults02Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:FourReportableSegmentResults02Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentAssets02Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2019-09-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2019-07-012019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2019-09-30in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares APOLLOHOSP 2019-04-01 2020-03-31 2019-09-25 INR Lakhs Half yearly Multi segment 2019-07-01 2019-09-30 Unaudited Standalone 24635800000.00 39400000.00 24675200000.00 3980200000.00 9249100000.00 -313200000.00 3809400000.00 1076900000.00 1203200000.00 4266100000.00 23271700000.00 1403500000.00 0.00 1403500000.00 582000000.00 -84500000.00 497500000.00 0.00 906000000.00 0.00 0.00 0.00 0.00 906000000.00 -3100000.00 902900000.00 902900000.00 0.00 695600000.00 5 6.51 6.51 0.00 0.00 6.51 6.51 0.01 0.03 0.06 1.tThe unaudited standalone financial results of Apollo Hospitals Enterprise Limited (“the Company”) for the three months and six months ended September 30, 2019 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on November 13, 2019 and November 14, 2019 respectively and have been subjected to limited review by the statutory auditors. n n2.tThe standalone statement of cash flow for the six months ended September 30, 2018 are approved by the Company’s Board of Directors but have not been subjected to limited review by the statutory auditors. n n3.tThe listed non-convertible debentures of the Company aggregating to Rs. 50,000 lakhs as on September 30, 2019 are secured by way of first charge on the Company's properties and the asset cover thereof exceeds hundred percent of the principal amount of the said debentures. n n4.tThe Company's debt instruments was assigned a rating of AA by CRISIL indicating a high degree of safety. 2019-04-01 2019-09-30 Unaudited Standalone 46927800000.00 86800000.00 47014600000.00 7627200000.00 17513400000.00 -593500000.00 7337800000.00 2076000000.00 2301300000.00 8140700000.00 44402900000.00 2611700000.00 0.00 2611700000.00 1154200000.00 -241600000.00 912600000.00 0.00 1699100000.00 0.00 0.00 0.00 0.00 1699100000.00 10400000.00 1709500000.00 1709500000.00 0.00 695600000.00 5 12.21 12.21 0.00 0.00 12.21 12.21 0.01 0.03 0.06 Other Expenses 4266100000.00 Other Expenses 8140700000.00 Healthcare services 12911800000.00 pharmacy 11726600000.00 Healthcare services 24637600000.00 pharmacy 22295000000.00 24638400000.00 46932600000.00 2600000.00 4800000.00 24635800000.00 46927800000.00 Healthcare services 1732500000.00 pharmacy 708500000.00 Healthcare services 3308700000.00 pharmacy 1292200000.00 2441000000.00 4600900000.00 1076900000.00 2076000000.00 -39400000.00 -86800000.00 1403500000.00 2611700000.00 Healthcare services 66586300000.00 pharmacy 15377200000.00 81963500000.00 14686000000.00 96649500000.00 Healthcare services 15377200000.00 pharmacy 9727700000.00 25104900000.00 37722800000.00 62827700000.00